Observational studyCancer medicine2023

Real-world effectiveness and safety of RC48-ADC alone or in combination with PD-1 inhibitors for patients with locally advanced or metastatic urothelial carcinoma: A multicenter, retrospective clinical study.

Jingwei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.